ResultsIQ › Latest results › Novartis India Limited
Novartis India Limited Q2 FY27 results deck summary
NSE: NOVARTIND · BSE: 500672
Results deck of 3 Nov 2026, summarised by AI from the filing.
The shift to direct sales to stockists replaced the single-customer model, with 20+ CFAs and 2000+ stockists onboarded.
Key takeaways
- Model change The shift to direct sales to stockists replaced the single-customer model, with 20+ CFAs and 2000+ stockists onboarded.
- Portfolio adds The Minipress XL acquisition and an ophthalmology in-licensing agreement added cardiology and ophthalmology platforms.
Novartis India Limited earnings call, investor presentation and press release summaries
Figures from the company's filings with NSE and BSE. Not investment advice.